within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AM03_EthambutolAndIsoniazid;
model EthambutolAndIsoniazid 
   extends Pharmacolibrary.Drugs.ATC.J.J04AM03;

  annotation(Documentation(
    info ="<html><body><p>Ethambutol and isoniazid is a fixed combination antituberculosis medication used primarily for the treatment of tuberculosis. Ethambutol acts by inhibiting cell wall synthesis, while isoniazid is a prodrug that inhibits the synthesis of mycolic acids. This combination is approved and widely used as part of multi-drug regimens for the treatment of tuberculosis.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics of ethambutol and isoniazid in adult patients with tuberculosis, administered orally as fixed-dose combination tablets.</p><h4>References</h4><ol><li><p>Denti, P, et al., &amp; Andersen, AB (2015). Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania. <i>PloS one</i> 10(10) e0141002–None. DOI:<a href=&quot;https://doi.org/10.1371/journal.pone.0141002&quot;>10.1371/journal.pone.0141002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26501782/&quot;>https://pubmed.ncbi.nlm.nih.gov/26501782</a></p></li><li><p>Sibley, L, et al., &amp; Sharpe, S (2022). Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of . <i>Pharmaceutics</i> 14(12) –. DOI:<a href=&quot;https://doi.org/10.3390/pharmaceutics14122666&quot;>10.3390/pharmaceutics14122666</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36559163/&quot;>https://pubmed.ncbi.nlm.nih.gov/36559163</a></p></li><li><p>Xu, J, et al., &amp; Lu, Y (2013). Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers. <i>Clinical therapeutics</i> 35(2) 161–168. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2013.01.003&quot;>10.1016/j.clinthera.2013.01.003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23410999/&quot;>https://pubmed.ncbi.nlm.nih.gov/23410999</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end EthambutolAndIsoniazid;
